Parkinsoni tõbi on krooniline neurodegeneratiivne haigus, mis mõjutab motoorikat, meeleolu ja kognitiivseid funktsioone. Kuigi täielikku ravi pole veel leitud, on üha enam tähelepanu pälvinud kanepiravi võimalused, eriti sümptomite leevendamisel.

1. Mida näitavad tänased teadusuuringud?

• Süsteemne ülevaade, mis hõlmas 5 kontrollitud ja 18 vaatlevat uuringut, leidis, et kanepi kasutamist Parkinsoni raviks ei saa veel täielikult soovitada, kuid täheldati potentsiaalseid eeliseid: vähenenud ärevus, parem uni, vähenenud valu ja paranenud üldine elukvaliteet.
  Allikas: PubMed – 2022
• Mitmed patsiendijuhud on näidanud leevendust sellistes sümptomites nagu värinad, jäikus, unetus ja ärevus. Mõned patsiendid kogesid ka paremat keskendumist ja emotsionaalset tasakaalu.
  Allikas:PCLA.org
  2025. aasta juhtumiuuringus kasutati väikestes doosides THC ja CBD ekstrakti ning märgati une kvaliteedi olulist paranemist 60 päeva jooksul. Mõnedel patsientidel täheldati ka kognitiivset paranemist.
        Allikas: Frontiers in Human Neuroscience

2. Kliinilised leiud ja uuringud

• 2023. aasta uuringus, kus osales 69 Parkinsoni patsienti, märkis 87% patsientidest sümptomite leevenemist vähemalt ühes aspektis. Lisaks suutis 56% neist vähendada või lõpetada opioidide tarbimist.
        Allikas: Psychopharmacology Institute
• Austria kliinilises uuringus testiti nabilooni – sünteetiline kannabinoid, mis mõjub sarnaselt THC-le – 47 Parkinsoni patsiendil. Tulemused näitasid paremat und ja vähem ärevust.
  Allikas: Parkinson’s UK

3. Ohutus ja piirangud

• Praegused uuringud on paljutõotavad, kuid piiratud väikeste valimite ja vähese standardiseerimise tõttu. On vaja ulatuslikke, randomiseeritud kliinilisi katseid.
  Allikad: Parkinson.org
• Võimalikud kõrvaltoimed: kognitiivne udu, peapööritus, nägemishäired. Eriti ettevaatlik tuleb olla kognitiivse langusega patsientide puhul.
• Pikaajaline kasutamine ei ole seostatud depressiooni ega kognitiivsete funktsioonide halvenemisega, kuid see nõuab veel kinnitamist.
  Allikas: ScienceDirect

4. Tulevikuvaade

• Arenduses on ka uued molekulid, mis võivad mõjutada Parkinsoni kulgu ilma THC kõrvaltoimeteta. Näiteks uuritakse praegu KLS-13019 molekuli, mille arendust toetab Michael J. Fox Foundation.
  Allikas: Wikipedia – Kannalife

Conclusion

Conclusion

Meditsiiniline kanep pakub Parkinsoni tõve sümptomite leevendamisel tõotavat suunda, eriti unehäirete, ärevuse ja valu puhul. Kuigi see ei ole imeravim, võib see olla tõhus toetav teraapia – eriti juhul, kui see toimub arstliku järelvalve ja teadusliku lähenemise raames.

ADHD (Attention Deficit Hyperactivity Disorder) is a neurodevelopmental disorder that affects a person’s ability to concentrate, control impulses, and regulate behavior. This condition often occurs in children but can persist into adulthood.

The main symptoms of ADHD are:

• Inattention – difficulty concentrating, forgetfulness, problems with organization.
• Hyperactivity – restlessness, constant need to move.
• Impulsivity – sudden reactions, impatience, impulsive behavior.

Can cannabinoids like CBD and CBG help with ADHD?

In recent years, cannabinoids—especially CBD (cannabidiol) and CBG (cannabigerol)—have gained significant attention for their potential in alleviating ADHD symptoms. Although research in this area is still limited, some individuals have found these natural substances helpful.

How do CBD and CBG affect ADHD?

CBD and CBG interact with the endocannabinoid system (ECS), which regulates mood, stress, focus, and sleep. Their potential effects on ADHD include:

1. Reducing anxiety and stress
   • CBD is known for its calming and anxiety-reducing properties, which can help with impulsivity and restlessness.
   • CBG may also assist in mood stabilization.
2. Improving focus and attention
   • Some studies and user experiences suggest that CBD may reduce "brain fog" and enhance the ability to concentrate.
   • CBG has neuroprotective effects and may support brain function.
3. Improving sleep quality
   • People with ADHD often experience sleep issues. CBD has shown potential to improve sleep quality and help with falling asleep faster.
4. Reducing impulsivity
   • Since CBD has a calming effect, it may help individuals better control their behavior and reduce sudden reactions.

CBD vs. CBG for ADHD

• CBD is better known and more widely used, particularly for its calming effects.
• CBG is less researched but may have a stronger impact on focus and cognitive support.

What does science say?

Although preliminary studies and anecdotal reports suggest potential benefits of cannabinoids, CBD and CBG have not yet been approved as official treatments for ADHD. They are also not substitutes for established ADHD medications like methylphenidate (Ritalin) or lisdexamfetamine (Elvanse).

How to use CBD or CBG for ADHD?

If you’re considering their use, it is recommended to:

• Start with a low dose and monitor your body’s response.
• Use only high-quality, lab-tested products.
• Consult a doctor, especially if you are taking ADHD medication, to avoid potential interactions.
• CBD and CBG can be consumed in various forms, such as oils, capsules, and crystals. Crystals offer faster effects, as they are quickly absorbed by the body.

Conclusion

While CBD and CBG may help alleviate some ADHD symptoms, they are not medications and do not replace proven medical treatments. If you decide to try them, do so cautiously and under professional guidance. Future research may provide more clarity on their real effectiveness in treating ADHD.

What is D9 THCV?

D9 THCV is a minor cannabinoid found mainly in naturally occurring cannabis strains from Africa, Asia, and the Middle East. Like other cannabinoids, it interacts with the human body's endocannabinoid system (ECS), which regulates various physiological processes such as mood, appetite, pain, and inflammation.

Unlike delta-9 THC, D9 THCV has a different chemical structure and mechanism of action, leading to unique interactions with ECS receptors, particularly CB1 and CB2 receptors.

How Does D9 THCV Work?

D9 THCV is often described as a "biphasic" compound due to its dual-action nature:

• At low dosesIn small amounts, D9 THCV acts as a CB1 receptor antagonist, potentially neutralizing the psychoactive effects of delta-9 THC. This makes it attractive to those seeking therapeutic benefits without experiencing a "high."
• At higher dosesIn larger amounts, D9 THCV can function as a CB1 receptor agonist, producing mild psychoactive effects, although significantly weaker than those of delta-9 THC.

Potential Benefits of D9 THCV

While research on D9 THCV is still in its early stages, preliminary studies and user experiences suggest several possible advantages:

1. Appetite Suppression
   Unlike delta-9 THC, which stimulates appetite ("the munchies"), D9 THCV may reduce appetite. This characteristic is being explored as a potential aid for weight management and metabolic health.
2. Increased Energy and Focus
   Many users report heightened energy levels, alertness, and mental clarity after consuming D9 THCV, often referring to it as the "sports car" of cannabinoids.
3. Blood Glucose Regulation
   Early studies suggest that D9 THCV may help regulate blood sugar levels and improve insulin sensitivity, offering potential benefits for managing diabetes, particularly type 2 diabetes.
4. Anti-Inflammatory Properties
   Like many other cannabinoids, D9 THCV may have anti-inflammatory effects, which could be beneficial for conditions such as arthritis or inflammatory bowel diseases.
5. Neuroprotective Effects
   Some studies indicate that D9 THCV may have neuroprotective properties, potentially aiding in the treatment of neurodegenerative diseases such as Parkinson’s or Alzheimer’s.

D9 THCV and EU Regulations

The legality of cannabinoids in the European Union depends primarily on their origin and THC content. The legal status of D9 THCV depends on whether it is derived from industrial hemp with a THC content below 0.3% or from medical cannabis. In the EU, all cannabinoid products must comply with relevant regulations, including general EU food safety laws if marketed as supplements.

Before purchasing or using D9 THCV products, it is crucial to check local regulations to ensure compliance with national laws.

How to Use D9 THCV?

D9 THCV is available in various forms, including oils, tinctures, supplements, and vape cartridges. The correct dosage depends on factors such as body weight, tolerance, and desired effects. New users are advised to start with a low dose and gradually increase it until the desired outcome is achieved.

Conclusion

D9 THCV is a fascinating cannabinoid with unique properties that have the potential to impact both the health and medical sectors. Its appetite-suppressing, energy-boosting, and metabolism-supporting effects make it a promising compound for future research and applications.

As with any new cannabinoid, consult a healthcare professional before use, especially if you have chronic conditions or take other medications.

These molecules lose their acid group and become decarboxylated becoming THC, CBD and CBC. Since CBG is "depleted" when converted to other states, plants with a high CBG content tend to have a low THCA or CBDA content and vice versa. CBGA is the parent molecule of many cannabinoids found in cannabis. Unlike its THC derivative, CBG is not psychoactive. It has shown interesting anti-inflammatory properties, as well as its ability to protect against neurons. Some studies have shown its ability to inhibit the growth of cancer cells; it is also an effective antibacterial, anti-spasmodic stimulant and stimulates appetite. Many of its benefits are similar to THCA and CBDAwhich makes sense as they are chemically similar. Before turning into THCA, CBDA, and CBCA, CBGA can take a different path through enzymatic changes and become CBGVA, which is the precursor to another type of cannabinoid: THCVA, CBDVA, and CBCVA. The letter V in this set of cannabinoids refers to cannabivarin classified as propyl cannabinoid; this group contains a propyl chain instead of a pentyl chain within the molecule. While this difference may suggest some variation in the effects of these cannabinoids, most of them act similarly to their pentyl cousins. The exception to this rule is THCV or tetrahydocannabivarin.
THCV: As a tetrahydrocannabivar As mentioned, THCV begins life as a CBGVA and is therefore modified by enzymes. It has a different ability than other cannabinoids to suppress appetite instead of stimulating it. No other known cannabinoid works in this way, and it is for this reason that THCV has attracted enormous interest in science. In addition to suppressing appetite, THCV has the ability to promote bone growth and healing.
CBC: Cannabichromene Another promising cannabinoid is CBC or Cannabichromene. Another common cannabinoid in CBC is a CBGA product such as THC and CBD. CBC appears to activate other secondary receptors, and for this reason it works well in topical preparations. Because of this, it can be used as a molecule in acne treatment, which significantly reduces excess sebum production in the skin. CBC has proven to be most effective for topical application. Combined with its antibacterial, anti-inflammatory and analgesic properties, it can be ideal for a wide variety of skin conditions. Finally, a complete blood count (CBC) stimulates spastic gastric motility without causing constipation, which is a secondary effect of many conventional medicines.
CBN: Kannabinool
Unlike other cannabinoids, which result from enzymatic changes within the plant, THC is converted to CBN after prolonged sun exposure in nature. It has traditionally been associated with “poor quality cannabis,” as high CBN levels tend to cause headaches and increase fatigue after smoking. However, we now know that a small amount of CBN is required to produce significant hypnotic effects, and 5 mg may be as effective as a 10 mg dose of diazepam, a common drug also used for sleep. As mentioned, all cannabinoids have a CBGA precursor. The plant then directs the CBGA to convert to other cannabinoids throughout its life cycle through synthesis, enzymes that chemically convert cannabinoids to other cannabinoids. This is determined by the needs of the plant and the amount of cannabinoid precursors available. We are still discovering the role that each of these cannabinoids plays in the plant, but we can safely assume that THCA, CBCA and CBDA benefit the plant to some extent because they appear in greater concentration in the plant. Most other cannabinoids, while potent and beneficial for medicinal purposes, don't seem to provide much to the plant. As a reminder, THC is actually present in very small amounts in the cannabis plant, as opposed to THCA, which is present in abundance (in relation to the species and genetic characteristics of cannabis). Only after additional research, selection, study of certain genetics and understanding of the cannabis plant and its natural mechanisms can we uncover the secrets of these unusual substances, "unusual cannabinoids".